Literature DB >> 34990021

PIP3 abundance overcomes PI3K signaling selectivity in invadopodia.

Charles T Jakubik1, Claire C Weckerly2, Gerald R V Hammond2, Anne R Bresnick1, Jonathan M Backer1,3.   

Abstract

PI3Kβ is required for invadopodia-mediated matrix degradation by breast cancer cells. Invadopodia maturation requires GPCR activation of PI3Kβ and its coupling to SHIP2 to produce PI(3,4)P2 . We now test whether selectivity for PI3Kβ is preserved under conditions of mutational increases in PI3K activity. In breast cancer cells where PI3Kβ is inhibited, short-chain diC8-PIP3  rescues gelatin degradation in a SHIP2-dependent manner; rescue by diC8-PI(3,4)P2  is SHIP2-independent. Surprisingly, the expression of either activated PI3Kβ or PI3Kα mutants rescued the effects of PI3Kβ inhibition. In both cases, gelatin degradation was SHIP2-dependent. These data confirm the requirement for PIP3 conversion to PI(3,4)P2 for invadopodia function and suggest that selectivity for distinct PI3K isotypes may be obviated by mutational activation of the PI3K pathway.
© 2022 Federation of European Biochemical Societies.

Entities:  

Keywords:  PI 3-kinase; invadopodia; matrix degradation

Mesh:

Substances:

Year:  2022        PMID: 34990021      PMCID: PMC8885911          DOI: 10.1002/1873-3468.14273

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   3.864


  35 in total

1.  Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β.

Authors:  Yoshito Nakanishi; Kimberly Walter; Jill M Spoerke; Carol O'Brien; Ling Y Huw; Garret M Hampton; Mark R Lackner
Journal:  Cancer Res       Date:  2016-01-12       Impact factor: 12.701

2.  SHIP2 Regulates Lumen Generation, Cell Division, and Ciliogenesis through the Control of Basolateral to Apical Lumen Localization of Aurora A and HEF 1.

Authors:  Ola Hamze-Komaiha; Sokavuth Sarr; Yannick Arlot-Bonnemains; Didier Samuel; Ama Gassama-Diagne
Journal:  Cell Rep       Date:  2016-12-06       Impact factor: 9.423

3.  GPCR Signaling Mediates Tumor Metastasis via PI3Kβ.

Authors:  Bassem D Khalil; Christine Hsueh; Yanyan Cao; Widian F Abi Saab; Yarong Wang; John S Condeelis; Anne R Bresnick; Jonathan M Backer
Journal:  Cancer Res       Date:  2016-03-24       Impact factor: 12.701

4.  Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer.

Authors:  Nir Ben-Chetrit; David Chetrit; Roslin Russell; Cindy Körner; Maicol Mancini; Ali Abdul-Hai; Tomer Itkin; Silvia Carvalho; Hadas Cohen-Dvashi; Wolfgang J Koestler; Kirti Shukla; Moshit Lindzen; Merav Kedmi; Mattia Lauriola; Ziv Shulman; Haim Barr; Dalia Seger; Daniela A Ferraro; Fresia Pareja; Hava Gil-Henn; Tsvee Lapidot; Ronen Alon; Fernanda Milanezi; Marc Symons; Rotem Ben-Hamo; Sol Efroni; Fernando Schmitt; Stefan Wiemann; Carlos Caldas; Marcelo Ehrlich; Yosef Yarden
Journal:  Sci Signal       Date:  2015-01-20       Impact factor: 8.192

5.  CRKL Mediates p110β-Dependent PI3K Signaling in PTEN-Deficient Cancer Cells.

Authors:  Jing Zhang; Xueliang Gao; Fabienne Schmit; Guillaume Adelmant; Michael J Eck; Jarrod A Marto; Jean J Zhao; Thomas M Roberts
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

6.  Coincident signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3Kβ in myeloid cells.

Authors:  Daniel M Houslay; Karen E Anderson; Tamara Chessa; Suhasini Kulkarni; Ralph Fritsch; Julian Downward; Jonathan M Backer; Len R Stephens; Phillip T Hawkins
Journal:  Sci Signal       Date:  2016-08-16       Impact factor: 8.192

Review 7.  Synergy in activating class I PI3Ks.

Authors:  John E Burke; Roger L Williams
Journal:  Trends Biochem Sci       Date:  2015-01-05       Impact factor: 13.807

8.  Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation.

Authors:  Hideki Yamaguchi; Shuhei Yoshida; Emi Muroi; Nachi Yoshida; Masahiro Kawamura; Zen Kouchi; Yoshikazu Nakamura; Ryuichi Sakai; Kiyoko Fukami
Journal:  J Cell Biol       Date:  2011-06-27       Impact factor: 10.539

9.  Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells.

Authors:  Alessandro Genna; Stefanie Lapetina; Nikola Lukic; Shams Twafra; Tomer Meirson; Ved P Sharma; John S Condeelis; Hava Gil-Henn
Journal:  J Cell Biol       Date:  2017-11-13       Impact factor: 10.539

10.  PI3Kβ links integrin activation and PI(3,4)P2 production during invadopodial maturation.

Authors:  Zahra Erami; Samantha Heitz; Anne R Bresnick; Jonathan M Backer
Journal:  Mol Biol Cell       Date:  2019-07-18       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.